BRAF and metastatic malignant neoplasm in the lymph nodes: Furthermore, in the low-risk group of the training set, the survival status, pathological stage I-II, T1-2, no lymph node metastasis, no distant metastasis, distant occurrence location, no RFS event and wild-type BRAF occurred more times (Figure 3C).